Establishment of Automated Culture System for Murine Induced Pluripotent Stem Cells

Overview

Journal BMC Biotechnol

Publisher Biomed Central

Specialty Biotechnology

Date 2012 Nov 7

PMID 23127273

Citations 7

Authors

Hiroyuki Koike

Koji Kubota

Keisuke Sekine

Takanori Takebe

Rie Ouchi

Yun-Wen Zheng

Yasuharu Ueno

Naoki Tanigawa

Hideki Taniguchi

Affiliations

Soon will be listed here.

Abstract

Background: Induced pluripotent stem (iPS) cells can differentiate into any cell type, which makes them an attractive resource in fields such as regenerative medicine, drug screening, or in vitro toxicology. The most important prerequisite for these industrial applications is stable supply and uniform quality of iPS cells. Variation in quality largely results from differences in handling skills between operators in laboratories. To minimize these differences, establishment of an automated iPS cell culture system is necessary.

Results: We developed a standardized mouse iPS cell maintenance culture, using an automated cell culture system housed in a CO2 incubator commonly used in many laboratories. The iPS cells propagated in a chamber uniquely designed for automated culture and showed specific colony morphology, as for manual culture. A cell detachment device in the system passaged iPS cells automatically by dispersing colonies to single cells. In addition, iPS cells were passaged without any change in colony morphology or expression of undifferentiated stem cell markers during the 4 weeks of automated culture.

Conclusions: Our results show that use of this compact, automated cell culture system facilitates stable iPS cell culture without obvious effects on iPS cell pluripotency or colony-forming ability. The feasibility of iPS cell culture automation may greatly facilitate the use of this versatile cell source for a variety of biomedical applications.

Citing Articles

Automated human induced pluripotent stem cell culture and sample preparation for 3D live-cell microscopy.

Gregor B, Coston M, Adams E, Arakaki J, Borensztejn A, Do T Nat Protoc. 2023; 19(2):565-594.

PMID: 38087082 DOI: 10.1038/s41596-023-00912-w.

Xeno-Free Materials for Stabilizing Basic Fibroblast Growth Factor and Enhancing Cell Proliferation in Human Pluripotent Stem Cell Cultures.

Masuzawa Y, Kitazawa M Materials (Basel). 2022; 15(10).

PMID: 35629712 PMC: 9144957. DOI: 10.3390/ma15103687.

Integrated, automated maintenance, expansion and differentiation of 2D and 3D patient-derived cellular models for high throughput drug screening.

Boussaad I, Cruciani G, Bolognin S, Antony P, Dording C, Kwon Y Sci Rep. 2021; 11(1):1439.

PMID: 33446877 PMC: 7809482. DOI: 10.1038/s41598-021-81129-3.

Effect of mechanical vibration stress in cell culture on human induced pluripotent stem cells.

Kanie K, Sakai T, Imai Y, Yoshida K, Sugimoto A, Makino H Regen Ther. 2020; 12:27-35.

PMID: 31890764 PMC: 6933472. DOI: 10.1016/j.reth.2019.05.002.

Towards standardized automated immunomonitoring: an automated ELISpot assay for safe and parallelized functionality analysis of immune cells.

Neubauer J, Sebastien I, Germann A, Muller S, Meyerhans A, von Briesen H Cytotechnology. 2016; 69(1):57-73.

PMID: 27896556 PMC: 5264623. DOI: 10.1007/s10616-016-0037-4.

References

Okita K, Ichisaka T, Yamanaka S . Generation of germline-competent induced pluripotent stem cells. Nature. 2007; 448(7151):313-7. DOI: 10.1038/nature05934. View

Hay D, Pernagallo S, Diaz-Mochon J, Medine C, Greenhough S, Hannoun Z . Unbiased screening of polymer libraries to define novel substrates for functional hepatocytes with inducible drug metabolism. Stem Cell Res. 2011; 6(2):92-102. DOI: 10.1016/j.scr.2010.12.002. View

Takahashi K, Yamanaka S . Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126(4):663-76. DOI: 10.1016/j.cell.2006.07.024. View

Thomson J, Itskovitz-Eldor J, Shapiro S, Waknitz M, Swiergiel J, Marshall V . Embryonic stem cell lines derived from human blastocysts. Science. 1998; 282(5391):1145-7. DOI: 10.1126/science.282.5391.1145. View

Stadtfeld M, Maherali N, Breault D, Hochedlinger K . Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell. 2008; 2(3):230-40. PMC: 3538379. DOI: 10.1016/j.stem.2008.02.001. View

Iwamuro M, Komaki T, Kubota Y, Seita M, Kawamoto H, Yuasa T . Hepatic differentiation of mouse iPS cells in vitro. Cell Transplant. 2010; 19(6):841-7. DOI: 10.3727/096368910X508960. View

Di Stefano B, Buecker C, Ungaro F, Prigione A, Chen H, Welling M . An ES-like pluripotent state in FGF-dependent murine iPS cells. PLoS One. 2011; 5(12):e16092. PMC: 3012723. DOI: 10.1371/journal.pone.0016092. View

Chan E, Ratanasirintrawoot S, Park I, Manos P, Loh Y, Huo H . Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat Biotechnol. 2009; 27(11):1033-7. DOI: 10.1038/nbt.1580. View

Thomson J, Kalishman J, Golos T, Durning M, Harris C, Becker R . Isolation of a primate embryonic stem cell line. Proc Natl Acad Sci U S A. 1995; 92(17):7844-8. PMC: 41242. DOI: 10.1073/pnas.92.17.7844. View

10.

Brambrink T, Foreman R, Welstead G, Lengner C, Wernig M, Suh H . Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell. 2008; 2(2):151-9. PMC: 2276627. DOI: 10.1016/j.stem.2008.01.004. View

11.

Xie H, Kim R, Wood A, Stein C . Molecular basis of ethnic differences in drug disposition and response. Annu Rev Pharmacol Toxicol. 2001; 41:815-50. DOI: 10.1146/annurev.pharmtox.41.1.815. View

12.

Greenhough S, Medine C, Hay D . Pluripotent stem cell derived hepatocyte like cells and their potential in toxicity screening. Toxicology. 2010; 278(3):250-5. DOI: 10.1016/j.tox.2010.07.012. View

13.

Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K . Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007; 131(5):861-72. DOI: 10.1016/j.cell.2007.11.019. View

14.

Park I, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A . Disease-specific induced pluripotent stem cells. Cell. 2008; 134(5):877-86. PMC: 2633781. DOI: 10.1016/j.cell.2008.07.041. View

15.

Palmqvist L, Glover C, Hsu L, Lu M, Bossen B, Piret J . Correlation of murine embryonic stem cell gene expression profiles with functional measures of pluripotency. Stem Cells. 2005; 23(5):663-80. DOI: 10.1634/stemcells.2004-0157. View

16.

Jin Z, Okamoto S, Osakada F, Homma K, Assawachananont J, Hirami Y . Modeling retinal degeneration using patient-specific induced pluripotent stem cells. PLoS One. 2011; 6(2):e17084. PMC: 3037398. DOI: 10.1371/journal.pone.0017084. View

17.

Hanna J, Cheng A, Saha K, Kim J, Lengner C, Soldner F . Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc Natl Acad Sci U S A. 2010; 107(20):9222-7. PMC: 2889088. DOI: 10.1073/pnas.1004584107. View

18.

Veraitch F, Scott R, Wong J, Lye G, Mason C . The impact of manual processing on the expansion and directed differentiation of embryonic stem cells. Biotechnol Bioeng. 2007; 99(5):1216-29. DOI: 10.1002/bit.21673. View

19.

Terstegge S, Laufenberg I, Pochert J, Schenk S, Itskovitz-Eldor J, Endl E . Automated maintenance of embryonic stem cell cultures. Biotechnol Bioeng. 2006; 96(1):195-201. DOI: 10.1002/bit.21061. View

20.

Xu Y, Zhu X, Hahm H, Wei W, Hao E, Hayek A . Revealing a core signaling regulatory mechanism for pluripotent stem cell survival and self-renewal by small molecules. Proc Natl Acad Sci U S A. 2010; 107(18):8129-34. PMC: 2889586. DOI: 10.1073/pnas.1002024107. View